ATE402707T1 - Imidazoä1,5aütriazoloä1,5dübenzodiazepin- derivative zur behandlung kognitiver störungen - Google Patents

Imidazoä1,5aütriazoloä1,5dübenzodiazepin- derivative zur behandlung kognitiver störungen

Info

Publication number: ATE402707T1
Authority: AT; Austria
Prior art keywords: imidazoä1; derivatives; treatment; cognitive disorders; formula
Prior art date: 2004-10-12

Application number

AT05797208T

Other languages

English (en)

Inventor

Henner Knust

Heinz Stadler

Andrew Thomas

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-12

Filing date

2005-10-04

Publication date

2008-08-15

2005-10-04 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2008-08-15 Application granted granted Critical

2008-08-15 Publication of ATE402707T1 publication Critical patent/ATE402707T1/de

Links

208000010877 cognitive disease Diseases 0.000 title 1
208000024827 Alzheimer disease Diseases 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
MEYXEJCDZRDIFZ-UHFFFAOYSA-N imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine Chemical class C=1N2N=CN=C2C2=CC=CC=C2N2CN=CC2=1 MEYXEJCDZRDIFZ-UHFFFAOYSA-N 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

AT05797208T 2004-10-12 2005-10-04 Imidazoä1,5aütriazoloä1,5dübenzodiazepin- derivative zur behandlung kognitiver störungen ATE402707T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP04105000		2004-10-12

Publications (1)

Publication Number	Publication Date
ATE402707T1 true ATE402707T1 (de)	2008-08-15

Family

ID=35427599

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05797208T ATE402707T1 (de)	2004-10-12	2005-10-04	Imidazoä1,5aütriazoloä1,5dübenzodiazepin- derivative zur behandlung kognitiver störungen

Country Status (14)

Country	Link
US (2)	US7671048B2 (de)
EP (1)	EP1809297B1 (de)
JP (1)	JP5117192B2 (de)
KR (1)	KR100869388B1 (de)
CN (1)	CN101039678B (de)
AT (1)	ATE402707T1 (de)
AU (1)	AU2005293820B2 (de)
BR (1)	BRPI0517412A (de)
CA (1)	CA2581918A1 (de)
DE (1)	DE602005008633D1 (de)
ES (1)	ES2312022T3 (de)
MX (1)	MX2007004250A (de)
RU (1)	RU2007112675A (de)
WO (1)	WO2006040038A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE477255T1 (de) *	2005-10-11	2010-08-15	Hoffmann La Roche	Imidazobenzdiazepinderivate
US10994357B2 (en) *	2006-12-20	2021-05-04	Lincoln Global, Inc.	System and method for creating or modifying a welding sequence
US8538675B2 (en)	2009-06-01	2013-09-17	Raytheon Company	Non-kinematic behavioral mapping
BR112013012072A2 (pt) *	2010-11-15	2016-08-16	Agenebio Inc	derivados, composições de benzodiazepina e métodos para o tratamento de danos cognitivos
DK3034079T3 (en)	2010-11-15	2018-02-05	Agenebio Inc	PYRIDAZINE DERIVATIVES, COMPOSITIONS AND PROCEDURES FOR TREATING COGNITIVE WEAKNESS
US20150374705A1 (en)	2012-02-14	2015-12-31	Shanghai Institues for Biological Sciences	Substances for treatment or relief of pain
CN112409363B (zh) *	2013-12-20	2023-11-14	艾吉因生物股份有限公司	用于治疗认知损害的苯并二氮杂䓬衍生物、组合物和方法
WO2016205739A1 (en)	2015-06-19	2016-12-22	Belew Mekonnen	Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US20180170941A1 (en) *	2016-12-19	2018-06-21	Agenebio, Inc.	Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US11505555B2 (en)	2016-12-19	2022-11-22	Agenebio, Inc.	Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
BR112019024987A2 (pt) *	2017-06-02	2020-06-16	Xeris Pharmaceuticals, Inc.	Formulações de fármaco de molécula pequena resistente à precipitação
BR112020026062B1 (pt)	2018-06-19	2023-04-04	Agenebio, Inc	Compostos derivados de benzodiazepina ou um sal farmaceuticamente aceitavel, isômero ou combinação dos mesmos, composição farmacêutica compreendendo os mesmos e usos dos mesmos para o tratamento de comprometimento cognitivo, câncer cerebral e psicose da doença de parkinson
CN111606926B (zh) *	2020-05-13	2021-10-15	大连理工大学	一种苯并咪唑[1,3]氮硫杂卓类化合物的制备方法
CN112979658B (zh) *	2021-02-22	2022-05-31	南湖实验室	一种氟马西尼的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1143728A (en)	1979-10-04	1983-03-29	Max Gerecke	Imidazodiazepine derivatives
EP0150040B1 (de) *	1984-01-19	1994-08-31	F. Hoffmann-La Roche Ag	Imidazodiazepin-Derivate
DK174086D0 (da) *	1986-04-16	1986-04-16	Ferrosan As	Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
US4897392A (en) *	1989-07-03	1990-01-30	Hoechst-Roussel Pharmaceuticals, Inc.	4H-indolo(1,2-d)(1,2,4)triazolo(4,3-A)(1,4)benzodiazepines
TW201311B (de) *	1991-06-17	1993-03-01	Hoffmann La Roche
TWI239333B (en) *	2000-11-16	2005-09-11	Hoffmann La Roche	Benzodiazepine derivatives as GABA A receptor modulators

2005
- 2005-10-04 DE DE602005008633T patent/DE602005008633D1/de not_active Expired - Lifetime
- 2005-10-04 WO PCT/EP2005/010655 patent/WO2006040038A1/en not_active Ceased
- 2005-10-04 RU RU2007112675/15A patent/RU2007112675A/ru not_active Application Discontinuation
- 2005-10-04 CA CA002581918A patent/CA2581918A1/en not_active Abandoned
- 2005-10-04 MX MX2007004250A patent/MX2007004250A/es active IP Right Grant
- 2005-10-04 CN CN2005800348517A patent/CN101039678B/zh not_active Expired - Fee Related
- 2005-10-04 KR KR1020077008246A patent/KR100869388B1/ko not_active Expired - Fee Related
- 2005-10-04 EP EP05797208A patent/EP1809297B1/de not_active Expired - Lifetime
- 2005-10-04 AU AU2005293820A patent/AU2005293820B2/en not_active Ceased
- 2005-10-04 JP JP2007536039A patent/JP5117192B2/ja not_active Expired - Fee Related
- 2005-10-04 BR BRPI0517412-0A patent/BRPI0517412A/pt not_active IP Right Cessation
- 2005-10-04 ES ES05797208T patent/ES2312022T3/es not_active Expired - Lifetime
- 2005-10-04 AT AT05797208T patent/ATE402707T1/de active
- 2005-10-07 US US11/245,736 patent/US7671048B2/en not_active Expired - Fee Related
2009
- 2009-11-16 US US12/618,802 patent/US8293730B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CN101039678A (zh)	2007-09-19
JP5117192B2 (ja)	2013-01-09
KR20070053324A (ko)	2007-05-23
US20060079507A1 (en)	2006-04-13
AU2005293820A1 (en)	2006-04-20
ES2312022T3 (es)	2009-02-16
RU2007112675A (ru)	2008-11-20
US8293730B2 (en)	2012-10-23
CA2581918A1 (en)	2006-04-20
BRPI0517412A (pt)	2008-10-07
US7671048B2 (en)	2010-03-02
MX2007004250A (es)	2007-06-12
EP1809297A1 (de)	2007-07-25
CN101039678B (zh)	2011-06-15
KR100869388B1 (ko)	2008-11-21
JP2008515941A (ja)	2008-05-15
DE602005008633D1 (de)	2008-09-11
WO2006040038A1 (en)	2006-04-20
EP1809297B1 (de)	2008-07-30
AU2005293820B2 (en)	2010-11-25
US20100075954A1 (en)	2010-03-25

Legal Events

Date

Code

Title

Description

2009-01-15

UEP

Publication of translation of european patent specification

Ref document number: 1809297

Country of ref document: EP

Publication	Publication Date	Title
ES2926775T3 (es)	2022-10-28	Proceso de preparación de intermedios sintéticos para la preparación de derivados de tetrahidroquinolina
AP1860A (en)	2008-07-02	Aryl fused azapolycyclic compounds.
NO20072046L (no)	2007-04-26	Halogensubstituerte benzodiazepinderivater
DE69730033T2 (de)	2005-07-21	Spirocyclisch metalloprotease inhibitoren
DE602005008633D1 (de)	2008-09-11	Imidazoä1,5aütriazoloä1,5dübenzodiazepin-derivative zur behandlung kognitiver störungen
ATE443063T1 (de)	2009-10-15	Ä1,2,4ütriazoloä4,3-aüpyridin-derivative zur behandlung hyperproliferativer erkrankungen
NO20071967L (no)	2007-05-14	Imidazo-benzodiazepinderivater
AU776000B2 (en)	2004-08-19	Methods of making and using N-desmethylzopiclone
TW200607807A (en)	2006-03-01	Macrocyclic beta-secretase inhibitors
FI112219B (fi)	2003-11-14	5H-indeno[1,2-b]pyratsin-2,3-dionijohdannaiset ja niitä sisältävät lääkeaineet
EA200701296A1 (ru)	2007-12-28	3,5-дизамещенные и 3,5,7-тризамещенные 3h-оксазоло- и 3h-тиазоло[4,5-d] пиримидин-2-оны и их пролекарства
MX2010004819A (es)	2010-07-05	Derivados de [1h-pirazolo[3,4-b]piridin-4-il]-fenilo o piridin-2-ilo como proteina cinasa c-theta.
JP2010520293A (ja)	2010-06-10	複素環式部分を含有するメタロプロテアーゼ阻害剤
ATE365742T1 (de)	2007-07-15	4-aminothieno(2,3-d) pyrimidin -6-carbonitril- derivative zur verwendung als pde7 inhibitoren
MXPA05009574A (es)	2006-05-19	Derivados de 8'-piridinil- dihidrospiro -[cicloalquil]- pirimido[1, 2a] pirimidin-6- ona y y 8'-pirimidinil- dihidrospiro -[cicloalquil]- pirimido [1, 2a]pirimidin-6 -ona substituidos y su uso contra enfermedades neurodegenerativas.
MXPA05013628A (es)	2006-02-24	Pirazolo[3,4-b]piridin-6-onas como inhibidores de gsk-3.
TWI617553B (zh)	2018-03-11	吖丁啶基氧苯基吡咯啶化合物
TN2020000160A1 (en)	2022-04-04	CHROMANE, ISOCHROMANE AND DIHYDROISOBENZOFURAN DERIVATIVES AS mGIuR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE
DE60221283D1 (de)	2007-08-30	Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden
WO2006026204A3 (en)	2006-07-27	Novel gamma-lactams as beta-secretase inhibitors
AU2011210829B2 (en)	2014-09-11	7-azoniabicyclo [2.2.1] heptane derivatives, methods of production, and pharmaceutical uses thereof
TW200631953A (en)	2006-09-16	Tetracyclic imidazo-benzodiazepines
ATE444069T1 (de)	2009-10-15	Chinolin-derivate zur behandlung von mglur5- rezeptor-vermittelten erkrankungen
DE602005017145D1 (de)	2009-11-26	Verwendung von opioid-rezeptorantagonisten zur prävention und/oder behandlung von erkrankungen im zusammenhang mit dem target calcineurin
WO2005007630A3 (en)	2005-04-28	Aryl fused azapolycyclic compounds